Results 221 to 230 of about 372,366 (307)

Catastrophic Multiple Recurrent Cerebral Ischemia in a Patient With Newly Diagnosed Hypereosinophilia. [PDF]

Neurohospitalist
Bagnato MR, Ferrante M, Saggese E, Di Ruzza MR, Di Donna MG.   +4 more
europepmc   +1 more source

Identification and functional analysis of microRNAs in rats following focal cerebral ischemia injury

, 2019
Xianchun Duan, Jianghua Gan, Daiyin Peng, Qiuyu Bao, Ling Xiao, Liangbing Wei, Jian Wu   +6 more
openalex   +2 more sources

Differential Recovery of Multimodal MRI and Behavior after Transient Focal Cerebral Ischemia in Rats [PDF]

, 2006
Kenneth M. Sicard, Nils Henninger, Marc Fisher, Timothy Q. Duong, Craig F. Ferris   +4 more
openalex   +1 more source

Retrospective, Multicenter Study of Lacosamide to Treat Neonatal Seizures

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Objective Most antiseizure medications (ASMs) are prescribed off label for neonates. Lacosamide's efficacy in infants and availability in intravenous formulation suggest potential utility for neonates. We evaluated the safety and efficacy of lacosamide for neonatal seizures. Methods This 10‐center, retrospective study of neonates with seizures
Alexandra Santana Almansa, Jessica R. Landers, Nicholas S. Abend, Giulia M. Benedetti, Catherine J. Chu, Andrew T. Knox, Shavonne Massey, Steffany Moen, Andrea C. Pardo, Arnold Sansevere, Renée A. Shellhaas, Cameron Thomas, Tammy Tsuchida, Sonya Wang, Bo Zhang, Janet S. Soul   +15 more
wiley   +1 more source

Cerebral ischemia-reperfusion injury: mechanisms and promising therapies. [PDF]

Front Pharmacol
Yang M, Liu B, Chen B, Shen Y, Liu G.
europepmc   +1 more source

Salvianolic acid for injection protected cerebral ischemia/reperfusion injury by autophagy regulation via PI3K/AKT/mTOR pathway in rats

Yuan Jing, Xiangbo Gou, Congxin Li, Wan Meixu   +3 more
openalex   +1 more source

Cardiovascular Risk of Romosozumab vs. Teriparatide: A Cohort Study Using Japan’s National Claims Database

Clinical Pharmacology &Therapeutics, EarlyView.
Disproportionality analyses suggested a cardiovascular risk signal for romosozumab, while statistically significant associations were not found in the real‐world database studies. Therefore, a larger comparative study was necessary to examine this signal.
Hotaka Maruyama, Eiko Iwasa, Shinya Watanabe, Tomoaki Hasegawa, Kazuhiro Kajiyama, Taihei Tanaka   +5 more
wiley   +1 more source

Neutrophil Extracellular Traps and Delayed Cerebral Ischemia in Patients With Subarachnoid Hemorrhage. [PDF]

J Am Heart Assoc
Schneider H, Münch D, Spalart V, Stroobants M, Berlis A, Maurer CJ, Jaschinski U, Kasner SE, Cao Q, Martinod K, Witsch J.   +10 more
europepmc   +1 more source

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Tetrahydrocurcumin Ameliorates Cerebral Ischemia-Reperfusion Injury and Restores Blood-Brain Barrier Dysfunction by Inhibiting Ferroptosis. [PDF]

CNS Neurosci Ther
Zhang S, Han J, Fan Z, Wang H, Liu L, Liu L, Zhou L, Deng H.   +7 more
europepmc   +1 more source